515 related articles for article (PubMed ID: 21246706)
1. Enumeration, characterization, and collection of intact circulating tumor cells by cross contamination-free flow cytometry.
Takao M; Takeda K
Cytometry A; 2011 Feb; 79(2):107-17. PubMed ID: 21246706
[TBL] [Abstract][Full Text] [Related]
2. Multicolor detection of rare tumor cells in blood using a novel flow cytometry-based system.
Watanabe M; Uehara Y; Yamashita N; Fujimura Y; Nishio K; Sawada T; Takeda K; Koizumi F; Koh Y
Cytometry A; 2014 Mar; 85(3):206-13. PubMed ID: 24327318
[TBL] [Abstract][Full Text] [Related]
3. Circulating tumor cells in metastatic colorectal cancer: efficacy and feasibility of different enrichment methods.
Königsberg R; Gneist M; Jahn-Kuch D; Pfeiler G; Hager G; Hudec M; Dittrich C; Zeillinger R
Cancer Lett; 2010 Jul; 293(1):117-23. PubMed ID: 20167419
[TBL] [Abstract][Full Text] [Related]
4. A combined micromagnetic-microfluidic device for rapid capture and culture of rare circulating tumor cells.
Kang JH; Krause S; Tobin H; Mammoto A; Kanapathipillai M; Ingber DE
Lab Chip; 2012 Jun; 12(12):2175-81. PubMed ID: 22453808
[TBL] [Abstract][Full Text] [Related]
5. EpCAM-independent capture of circulating tumor cells with a 'universal CTC-chip'.
Chikaishi Y; Yoneda K; Ohnaga T; Tanaka F
Oncol Rep; 2017 Jan; 37(1):77-82. PubMed ID: 27840987
[TBL] [Abstract][Full Text] [Related]
6. Cysteine-poor region-specific EpCAM monoclonal antibody recognizing native tumor cells with high sensitivity.
Takao M; Nagai Y; Torii T
Monoclon Antib Immunodiagn Immunother; 2013 Apr; 32(2):73-80. PubMed ID: 23607341
[TBL] [Abstract][Full Text] [Related]
7. Application of immunomagnetic cell enrichment in combination with RT-PCR for the detection of rare circulating head and neck tumor cells in human peripheral blood.
Tong X; Yang L; Lang JC; Zborowski M; Chalmers JJ
Cytometry B Clin Cytom; 2007 Sep; 72(5):310-23. PubMed ID: 17205568
[TBL] [Abstract][Full Text] [Related]
8. Molecular characterization of circulating tumor cells in large quantities of contaminating leukocytes by a multiplex real-time PCR.
Sieuwerts AM; Kraan J; Bolt-de Vries J; van der Spoel P; Mostert B; Martens JW; Gratama JW; Sleijfer S; Foekens JA
Breast Cancer Res Treat; 2009 Dec; 118(3):455-68. PubMed ID: 19115104
[TBL] [Abstract][Full Text] [Related]
9. Microsieve lab-chip device for rapid enumeration and fluorescence in situ hybridization of circulating tumor cells.
Lim LS; Hu M; Huang MC; Cheong WC; Gan AT; Looi XL; Leong SM; Koay ES; Li MH
Lab Chip; 2012 Nov; 12(21):4388-96. PubMed ID: 22930096
[TBL] [Abstract][Full Text] [Related]
10. Detection and quantification of circulating tumor cells in mouse models of human breast cancer using immunomagnetic enrichment and multiparameter flow cytometry.
Allan AL; Vantyghem SA; Tuck AB; Chambers AF; Chin-Yee IH; Keeney M
Cytometry A; 2005 May; 65(1):4-14. PubMed ID: 15810015
[TBL] [Abstract][Full Text] [Related]
11. Detection of circulating tumor cells in breast cancer may improve through enrichment with anti-CD146.
Mostert B; Kraan J; Bolt-de Vries J; van der Spoel P; Sieuwerts AM; Schutte M; Timmermans AM; Foekens R; Martens JW; Gratama JW; Foekens JA; Sleijfer S
Breast Cancer Res Treat; 2011 May; 127(1):33-41. PubMed ID: 20379845
[TBL] [Abstract][Full Text] [Related]
12. Imaging cytometry for counting circulating tumor cells: comparative analysis of the CellSearch vs ImageStream systems.
López-Riquelme N; Minguela A; Villar-Permuy F; Ciprian D; Castillejo A; Álvarez-López MR; Soto JL
APMIS; 2013 Dec; 121(12):1139-43. PubMed ID: 23510386
[TBL] [Abstract][Full Text] [Related]
13. An immunomagnetic epithelial tumor cell enrichment model for minimal residual disease detection of cytokeratin 8+ malignancies.
Brooimans RA; de Leeuw N; Bontenbal M; Gratama JW
J Biol Regul Homeost Agents; 2005; 19(1-2):84-91. PubMed ID: 16178280
[TBL] [Abstract][Full Text] [Related]
14. FISH-based determination of HER2 status in circulating tumor cells isolated with the microfluidic CEE™ platform.
Mayer JA; Pham T; Wong KL; Scoggin J; Sales EV; Clarin T; Pircher TJ; Mikolajczyk SD; Cotter PD; Bischoff FZ
Cancer Genet; 2011 Nov; 204(11):589-95. PubMed ID: 22200084
[TBL] [Abstract][Full Text] [Related]
15. Cytometric characterization of circulating tumor cells captured by microfiltration and their correlation to the CellSearch(®) CTC test.
Adams DL; Stefansson S; Haudenschild C; Martin SS; Charpentier M; Chumsri S; Cristofanilli M; Tang CM; Alpaugh RK
Cytometry A; 2015 Feb; 87(2):137-44. PubMed ID: 25515318
[TBL] [Abstract][Full Text] [Related]
16. Microfluidic flow fractionation device for label-free isolation of circulating tumor cells (CTCs) from breast cancer patients.
Hyun KA; Kwon K; Han H; Kim SI; Jung HI
Biosens Bioelectron; 2013 Feb; 40(1):206-12. PubMed ID: 22857995
[TBL] [Abstract][Full Text] [Related]
17. Enumeration of Circulating Tumor Cells and Disseminated Tumor Cells in Blood and Bone Marrow by Immunomagnetic Enrichment and Flow Cytometry (IE/FC).
Magbanua MJM; Solanki TI; Ordonez AD; Hsiao F; Park JW
Methods Mol Biol; 2017; 1634():203-210. PubMed ID: 28819853
[TBL] [Abstract][Full Text] [Related]
18. Enrichment of rare cancer cells through depletion of normal cells using density and flow-through, immunomagnetic cell separation.
Lara O; Tong X; Zborowski M; Chalmers JJ
Exp Hematol; 2004 Oct; 32(10):891-904. PubMed ID: 15504544
[TBL] [Abstract][Full Text] [Related]
19. Fluorescence-expressing viruses allow rapid identification and separation of rare tumor cells in spiked samples of human whole blood.
Fong SM; Lee MK; Adusumilli PS; Kelly KJ
Surgery; 2009 Sep; 146(3):498-505. PubMed ID: 19715807
[TBL] [Abstract][Full Text] [Related]
20. A novel method for downstream characterization of breast cancer circulating tumor cells following CellSearch isolation.
Frithiof H; Welinder C; Larsson AM; Rydén L; Aaltonen K
J Transl Med; 2015 Apr; 13():126. PubMed ID: 25896421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
